Trials / Completed
CompletedNCT03448640
Efficacy of Mydriatic Drops in Premature Infants
Efficiency and Safety of Phenylephrine and Tropicamide Used in Premature Retinopathy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- Bulent Ecevit University · Academic / Other
- Sex
- All
- Age
- 32 Weeks – 34 Weeks
- Healthy volunteers
- Not accepted
Summary
Because of the neonatologists reported that some infants had suffered from vomiting, bradycardia, hypotonia, and aspiration risk about 30-60 minutes after the fundus examination in the intensive care unit. The investigators observed the pupil dilation effects and side effects of tipple instillation of phenylephrine 2.5% plus tropicamide 0.5% ophthalmic drop combination which the investigators routinely used in ROP examination.
Detailed description
Purpose: To determine effect and vital change after topical application of phenylephrine 2.5% and tropicamide 0.5% three times for retinopathy of prematurity (ROP) examination in preterm infants. Methods: Pupillary diameter, blood pressure, pulse rate, and oxygen saturation were monitored before, and after up to 24 hours 60 ROP screening examinations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Drug used in the examination of premature infants. | to investigate side effects of eye drops used |
Timeline
- Start date
- 2016-01-15
- Primary completion
- 2017-10-15
- Completion
- 2017-12-15
- First posted
- 2018-02-28
- Last updated
- 2018-02-28
Source: ClinicalTrials.gov record NCT03448640. Inclusion in this directory is not an endorsement.